Pulmicort Nebuamp - (0.125 mg/mL, 0.25 mg/mL, 0.5 mg/mL)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type III
| Lot or serial number | Brand name | Companies | Dosage form | DIN, NPN, DIN-HIM | Strength |
|---|
| WT0023, AC0180, AN0086 | B. Pulmicort Nebuamp 0.25 mg/mL | - Recalling Firm
- AstraZeneca Canada Inc. 1004 Middlegate Road Mississauga, Ontario L4Y 1M4
- Marketing Authorization Holder
- AstraZeneca Canada Inc. 1004 Middlegate Road Mississauga, Ontario L4Y 1M4
| 2 mL ampoules | DIN 01978918 | 0.25 mg/mL |
| AB0126 | C. Pulmicort Nebuamp 0.5 mg/mL | - Recalling Firm
- AstraZeneca Canada Inc. 1004 Middlegate Road Mississauga, Ontario L4Y 1M4
- Marketing Authorization Holder
- AstraZeneca Canada Inc. 1004 Middlegate Road Mississauga, Ontario L4Y 1M4
| 2 mL ampoules | DIN 01978926 | 0.5 mg/mL |
| YM0042 | A. Pulmicort Nebuamp 0.125 mg/mL | - Recalling Firm
- AstraZeneca Canada Inc. 1004 Middlegate Road Mississauga, Ontario L4Y 1M4
- Marketing Authorization Holder
- AstraZeneca Canada Inc. 1004 Middlegate Road Mississauga, Ontario L4Y 1M4
| 2 ml ampoules | DIN 02229099 | 0.125 mg/mL |
Recalled Products
Pulmicort Nebuamp - 0.125 mg/mL, 0.25 mg/mL, 0.5 mg/mL
Budesonide content in a small number of ampoules may be above or below the specification range.